Fennec Pharmaceuticals Inc (FENC)
EBITDA Growth
169.56%
Quarterly · Period ending:
FENC EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported169.56%period ending
Latest reported169.56%period ending
FENC Quarterly EBITDA YoY % (-23.90% → 169.56%)
Year-over-year change
High-resolution chart · PNG
FENC ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 169.5618% | |
| 142.7788% | |
| -592.1975% | |
| 99.445% | |
| 43.4977% | |
| -103.7481% | |
| 62.9935% | |
| -398.935% | |
| 1.3858% | |
| 381.6287% | |
| 71.9179% | |
| 88.1229% | |
| 9.2071% | |
| -42.7155% | |
| -38.6964% | |
| -91.8001% | |
| -25.4259% | |
| 23.2184% | |
| -30.2152% | |
| 33.5161% | |
| 17.6058% | |
| -23.3116% | |
| 8.4041% | |
| -232.7966% | |
| -0.6649% | |
| -43.097% | |
| -17.649% | |
| 34.5857% | |
| -86.0456% | |
| -70.9184% | |
| -23.4592% | |
| -30.2836% | |
| -74.9155% | |
| -103.3722% | |
| -119.459% | |
| -287.5887% | |
| -109.1938% | |
| -69.8238% | |
| -107.9855% | |
| -66.8639% | |
| -28.7796% | |
| -0.4425% | |
| -180.2038% | |
| 45.3958% | |
| 40.9677% | |
| 15.8287% | |
| -38.1638% | |
| 64.949% | |
| -0.3236% | |
| 0% | |
| 141.6729% | |
| -131.1518% | |
| -53.9867% | |
| -119.779% | |
| -136.9201% | |
| 19.0678% | |
| -5.2448% | |
| 365.9158% | |
| 984.9265% | |
| -2.9444% | |
| 77.7345% | |
| -178.9617% | |
| -292.9078% | |
| -1,139.1892% | |
| -167.3257% | |
| 81.25% | |
| 116.1697% | |
| 97.7473% | |
| 72.2415% | |
| 55.2191% | |
| 17.189% | |
| 3.3824% | |
| -2.3957% | |
| -7.4174% | |
| 33.8024% | |
| 27.6134% | |
| 13.728% | |
| -24.9769% | |
| 37.2555% | |
| -16.4952% | |
| 6.3364% | |
| -22.6219% | |
| -15.4807% | |
| -60.0578% | |
| -80.3668% | |
| -30.0043% | |
| -338.8212% | |
| -143.2075% | |
| -44.2495% | |
| -56.3193% | |
| -61.4107% | |
| 7.6802% | |
| -10.9332% | |
| -48.2294% | |
| -39.05% | |
| -20.6986% | |
| 45.2709% | |
| -23.9001% |